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Dendritic Cells Utilize the Evolutionarily Conserved
WASH and Retromer Complexes to Promote MHCII
Recycling and Helper T Cell Priming
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Abstract
Immature dendritic cells (DCs) maintain a highly dynamic pool of recycling MHCII that promotes sampling of environmental
antigens for presentation to T helper cells. However, the molecular basis of MHCII recycling and the cellular machinery that
orchestrates MHCII trafficking are incompletely understood. Using a mouse model we show that WASH, an actin regulatory
protein that facilitates retromer function, is essential for MHCII recycling and efficient priming of T helper cells. We further
demonstrate that WASH deficiency results in impaired MHCII surface levels, recycling, and an accumulation of
polyubiquitinated MHCII complexes, which are subsequently slated for premature lysosomal degradation. Consequently,
conditional deletion of the Wash gene in DCs impairs priming of both conventional and autoimmune T helper cells in vivo
and attenuates disease progression in a model of experimental autoimmune encephalitis (EAE). Thus, we identify a novel
mechanism in which DCs employ the evolutionarily conserved WASH and retromer complex for MHCII recycling in order to
regulate T helper cell priming.
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of pMHCII complexes and that recycling facilitates the display of
antigenic peptides to T helper cells [8,15,17–23]. Using multidimensional RNAi screening, Paul et al. found multiple proteins that
play a role in MHCII gene expression and MHCII transport to the
surface [24–28]. Studies examining MHCII transport from the
plasma membrane through the endosomal network have mainly
concentrated on the internalization of MHCII. Internalization of
MHCII from the plasma membrane is thought to involve clathrinmediated endocytosis, but it may also occur in a clathrinindependent manner involving lipid rafts and the activity of Arf6
GTPases [8,29–31]. Once MHCII enters the endosomal compartment, its trafficking itinerary is not well characterized. From
early endosomes, MHCII is thought to be transported to a peptide
loading compartment referred to as the MHC class II-enriched
compartment, which is likely a late endosome or multivesicular
body [15,20,22]. Here, a critical sorting step occurs in which
MHCII is either recycled or targeted for degradation via
ubiquitination of a conserved lysine residue in the MHCIIb chain
[8,18,19]. In DCs, March1 ubiquitinates MHCII [17,20–23], thus
ostensibly marking it for recognition by the ESCRT complex,
which transports cargo into luminal vesicles within the multivesicular body [7,9,15,28,32–35]. From here, MHCII is degraded in
either lysosomes or multilamellar bodies [19,24,27,28]. Efficient

Introduction
The unique ability of DCs to sample their environment and
present exogenous antigens on surface MHCII is essential for
priming antigen-specific naive T lymphocytes [1–3]. At steady
state, immature DCs survey their environment by constitutive
macropinocytosis and phagocytosis [4–6] while maintaining a
dynamic intracellular pool of MHCII for antigenic peptide loading
[7–10]. Although immature DCs are highly efficient at antigen
acquisition and processing, peptide-MHCII (pMHCII) complexes
are labile as a result of rapid recycling and degradation [8,9,11–
13]. Upon stimulation by pathogen-associated molecular patterns
or inflammatory mediators, DCs undergo a rapid maturation that
results in the down regulation of antigen uptake and pMHCII
recycling [8,11,12,14,15]. As a result, DC maturation leads to the
accumulation of surface pMHCII complexes bearing antigenic
peptides encountered at the time of pathogen exposure or
inflammatory insult [8,16]. Consequently, DCs are adept at
persistent display of antigenic pMHCII complexes on the plasma
membrane to promote stable interactions with antigen-specific T
cells.
Several previous studies have shown that efficient recycling of
pMHCII in DCs is critical for preventing premature degradation
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recycling of MHCII spares it from the degradation pathway. We
previously reported that the immunoreceptor tyrosine-based
activation motif (ITAM) signaling pathway is required for efficient
MHCII recycling and antigen presentation [23,24]. However, the
cellular machinery responsible for recycling has not been defined.
MHCII is known to enter the endosomal compartment, but
how it recycles and escapes delivery to the lysosome remains
unclear [27,30]. The retromer complex was shown to recycle
mannose-6-phosphate receptors and G-protein coupled receptors
from the endosomal compartment, thus sparing them from
lysosomal degradation [18–20,24,36,37]. In this context, the
retromer complex is traditionally known for its role in directing
retrograde trafficking of endosomal membrane components to the
trans Golgi network [23,38,39], however emerging evidence
indicates that retromer components also direct endosomal cargo
to the plasma membrane [24,26–28,32,38]. In both cases, the
retromer functions in cargo recognition and endosomal tubulation
with the vacuolar protein sorting subunits (VPS26, VPS29, and
VPS35) functioning as a coat complex, while the sorting nexin
subunits (SNX1, SNX2, SNX5, and SNX6) drive endosomal
tubulation [7,9,28,32,33,38,40].
The discovery of the WASP family protein WASH was a major
advancement in understanding actin-dependent receptor trafficking from the endosome. WASH functionally coordinates retromer
activity with actin cytoskeletal remodeling to maintain endosomal
structure and facilitate receptor trafficking by the retromer
[7,9,10,28,33,40]. WASH itself contains a VCA domain, which
recruits and activates the Arp2/3 complex, leading to polymerization of branched actin networks on endosomes [7,10,41].
Although WASH is constitutively active with respect to Arp2/3mediated actin polymerization in vitro, it is maintained in an
inactive state in intact cells by the WASH regulatory complex
(SHRC), which is comprised of Strumpellin, SWIP, FAM21, and
CCDC53 [7,10,40–42]. In addition to maintaining WASH in an
inactive state, the WASH complex member FAM21 recruits the
complex to the retromer through a direct interaction with VPS35
[40,42,43]. WASH activity toward Arp2/3 is subsequently
stimulated by K63-linked ubiquitination by the retromer-recruited
TRIM27-MAGEL2-Ube20 ubiquitin ligase complex [9,11,43].
Here, we have identified a novel mechanism in which DCs employ
WASH and the evolutionarily conserved retromer machinery for
MHCII recycling from the endosomal compartment back to the
plasma membrane. Loss of WASH or the essential retromer
component VPS35 impairs MHCII recycling and antigen
presentation by DCs.

DC cultures and shRNA knockdown
Bone marrow derived DCs (BMDCs) were cultured in GM-CSF
as previously described [23,46]. Short hairpin RNA constructs
cloned into pLKO.1 lentiviral vector (the RNAi Consortium) were
obtained from the Genome Institute at Washington University.
Constructs
targeting
luciferase
(AGTACTTCGAAATGTCCGTTC) or murine VPS35 (GCTGTCACCAAAGAGTTACTA) were transfected into HEK 293T cells along with
pCMV-dR8.91 and VSV-G constructs to generate lentiviral
particles. At 24 hours post- transfection, cell culture media was
exchanged, and lentiviral supernatants were harvested 24 hours
later. In parallel, BMDCs were harvested after two days in culture
and ‘‘spinfected’’ with fresh lentiviral supernatant for 60 min.
BMDCs were resuspended, diluted 1:4 in fresh media, and
cultured for 2 more days. At this time point, cultures were selected
in puromycin (4 mg/ml) for the last 2 days of culture.

MHCII surface retention
To determine MHCII cell surface retention in DCs, we turned
to an assay we previously developed [7,23,42]. The MHCII cell
surface retention assay was set up such that identical replicate
samples were used for each time point after chase. Thus, we were
able to monitor change in MHCII surface expression relative to
time 0 (or untreated). Indeed, during extensive assay development,
we have determined this approach to be the most quantitative and
robust protocol relative to other iterations we tested. Furthermore,
data from the surface retention assay are consistent with
biochemical and cell biological approaches we have pursued
[7,23,42]. In brief, BMDCs were treated with or without
Brefeldin-A (GolgiPlug protein transport inhibitor BD Biosciences
at 1:1000). At time 0 and after 5 hours in Brefeldin-A, cells were
stained with anti-CD11c-APC (BD Biosciences) and anti-I-AbFITC (BD Biosciences) and analyzed by flow cytometry. The
mean fluorescence intensity of MHCII at 5 hours was determined
and expressed as a percent of the mean fluorescence intensity at
time 0.

Immunofluorescence (IF)
BMDCs were cultured on #1.5 LabTek II eight-chambered
coverslips (Nunc) for at least 30 minutes to allow firm adhesion.
Cells were fixed by addition of ice-cold fixative (4% paraformaldehyde and 0.5% glutaraldehyde in PBS) and incubated for
30 min at room temperature in the dark, followed by permeabilization with 0.2% Triton X-100 in PBS for 15 min. Cells were
then cultured with 10 mg/ml primary antibodies (Abs) in IF buffer
(TBS plus human serum cocktail) overnight at 4uC in a humidifier
chamber. Primary Abs consist of a mouse monoclonal anti-I-Ab
(Biolegend), rat polyclonal anti-LAMP1 (BD Biosciences), and
rabbit polyclonal anti-WASH and anti-VPS35 antibodies
[7,16,42] diluted in IF buffer. Following 5–6 washes in PBS, cells
were incubated with secondary Abs (1:500 dilution in imaging
buffer) for 1 hr at room temperature. After 5–6 washes with PBS
and addition of Hoechst 33342 nuclear stain, SlowFade Gold
antifade reagent (Molecular Probes) was added to the wells.
Images were obtained with an LSM-710 laser scanning confocal
microscope with a 100X/1.4 Oil Plan-Aprochromat objective lens
using ZEN software (Carl Zeiss). Each image represents an
individual slice taken from a z-stack comprised of several slices at
0.25 mm depth.

Materials and Methods
Mice
Generation of mice with conditional Wash allele has been
described previously [9,11,44]. In brief, the endogenous Wash gene
was floxed (WASHfl/fl) by standard gene targeting technology and
bred to LysM-Cre [44,45] (Jackson Labs), Vav-Cre (Gift from Dr.
Thomas Graf, Albert Einstein College) or CD11c-Cre mice
[45,46] (Jackson Labs). OT-II mice were a gift from H. Virgin
(Washington University, St Louis, MO). Mice were bred on a
C57BL/6 background.

Ethics
All animal procedures were performed in accordance with
institutional guidelines and approved by the Animal Studies
Committee at Washington University School of Medicine in St
Louis, MO (20120250) and Mayo Clinic Institutional Animal Care
and Use Committee in Rochester, MN (A25413).
PLOS ONE | www.plosone.org

MHCII endocytosis assay
To specifically track the localization of surface-derived MHCII
after endocytosis, we performed an IF directed endocytosis assay.
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BMDCs were cultured on #1.5 LabTek II eight-chambered
coverslips as described above. After 30 min culture, the cell media
was replaced with serum-free DMEM containing 10 mg/ml anti-IAb (Biolegend) and then incubated at 37uC for 30 min to allow
internalization. Cells were then prepared for immunofluorescence
using the protocol described above.

APC. After a wash in FACS buffer, cells were resuspended in
500 ml FACS buffer and analyzed using a flow cytometry. Data
were analyzed using FlowJo 8.8.7 software.

MHCII Ubiquitination
Dendritic cells (156106/sample) were lysed for 10 min on ice in
1 ml of lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris-HCl,
2 mM EDTA, 20 mM N-ethylmaleimide, supplemented with
complete protease inhibitors (Roche), pH 7.2). Protein A/G
sepharose (Pierce Biotechnology) and 3 mg of anti-MHCII (clone
M5/114) were added to lysates for immunoprecipitation at 4uC
overnight. Samples were washed 3 times in lysis buffer, eluted in
Laemmli sample buffer by boiling, resolved by PAGE on a 10%
gel, and transferred to PVDF membranes (Millipore). Membranes
were then sequentially blotted with antibodies specific for ubiquitin
(clone P4D1, Santa Cruz Biotechnology) or MHCII bchain (clone
KL295, ATCC). Primary antibodies were detected with HRPcoupled anti-mouse IgG antibodies (Zymed) and developed using
ECL (GE Healthcare).

Image Analysis
Co-localization was assessed by Pearson’s correlation coefficient
and overlap coefficient using ZEN software (Carl Zeiss). Fluorescent puncta and size were measured using single slice images and
Analyze Particles in Image J (National Institutes of Health: http;//
rsb.info.nih.gov/ij/).

MHCII half-life
BMDCs were surface biotinylated (56106 cells/100 ml in PBS
pH 8.0) with Sulfo-NHS-SS-Biotin (Pierce Biotechnology) at a
concentration of 0.5 mg/ml for 30 min on ice. After washing in
PBS 10 mM glycine, cells were chased at 37uC for the indicated
time points in complete media. Cells were then lysed for 5 min on
ice in 1 ml of lysis buffer (1% NP-40, 150 mM NaCl, 50 mM TrisHCl, 2 mM EDTA, supplemented with complete protease
inhibitors (Roche), pH 7.2). Protein A/G sepharose (Pierce
Biotechnology) was added to lysates along with 2.5 mg of antiMHCII (clone M5/114) for immunoprecipitation at 4uC overnight. Samples were washed 3 times in lysis buffer, eluted in nonreducing 26 Laemmli sample buffer, and resolved by PAGE on a
10% gel. Proteins were then transferred from the gel to PVDF
membranes (Millipore) that were then blotted with streptavidinHRP (Southern Biotechnology) and developed using ECL
substrate (GE Healthcare). After developing the blots, Image J
software was used for densitometric measurement of band
intensity (in units of mean integrated pixel density).

Antigen Presentation Assays
CD4+ OT-II T cells were purified from spleens and lymph
nodes by negative selection with MACS beads (Miltenyi Biotec)
and then labeled with CFSE (Vybrant CFDA SE cell tracer kit,
Invitrogen) according to manufacturer’s instructions. T cells
(1006103) were mixed with DCs (206103) in round-bottom 96well plates with the indicated doses of OT-II peptide (Ova323-339)
(a gift from P.M. Allen, Washington University). Alternatively,
BMDCs were pulsed with OT-II peptide (100 nM) in serum free
media for 1.5 hours at 37uC, followed by thorough washing, and
cultured at the indicated cell number with OT-II T cells (1006103)
for three days. Subsequently, T cells were stained with anti-CD4APC (clone GK1.5, Becton Dickinson) and analyzed on a
FACSCaliber flow cytometer (Becton Dickinson) with FlowJo
software. Proliferation was determined by cell count of CD4positive CFSE-positive cells.

MHCII recycling assay
BMDCs of the indicated genotypes were surfaced labeled with
an anti-I-Ab-APC antibody (BD Biosciences) for 30 min, washed
in DC culture media (RPMI-10% FBS + GM-CSF + IL-4), and
incubated for 30 min to allow internalization. Cells were then
spun down and resuspended in FACS buffer stripping solution
(PBS containing 2% BSA Fraction V [Sigma Aldrich] and 0.1%
NaN3, pH 1.5) for 10 min on ice and washed in stripping solution.
Cells were then washed in cold FACS buffer (pH 7.4 PBS
containing 2% BSA Fraction V [Sigma Aldrich] and 0.1% NaN3)
and resuspended in DC culture media. Resuspended DCs were
then incubated for 0, 10, 20 and 40 min to allow resurfacing of the
internalized I-Ab. Following incubation, cells again were spun
down and resuspended in FACS buffer stripping solution for
10 min on ice and washed in stripping solution. Cells were then
washed, resuspended in 500 ml FACS buffer and analyzed by flow
cytometry using a FACSCanto II flow cytometer (BD Biosciences).
Data were analyzed using FlowJo 8.8.7 software (Tree Star,
Ashland, OR). The percentage of recycled I-Ab was measured
using the equation (T0 – Tx)/T06100. T0 represents the mean
fluorescence of cells following the second acid strip at time zero
and Tx is the mean fluorescence intensity of cells stripped at each
time point. The acid stripping method was adapted from Sullivan
et al. [16,23].

Ovalbumin Immunizations
WASHfl/fl CD11c-Cre mice and controls (6–8 weeks old) were
immunized with 10 nmoles of the OVA323-339 peptide emulsified
with complete Freund’s adjuvant (Sigma Aldrich). Mice were
injected subcutaneously into the hind footpad, and at seven days
after immunization, the popliteal draining lymph nodes were
harvested and processed into single cell suspensions for subsequent
analyses.

ELISPOT Assays
MultiScreen – IP sterile 96-well filtration plates with 0.45 mm
hydrophobic high protein binding Immobilon-P membrane
(Millipore) were pre-wet with 70% ethanol, washed with PBS,
and then coated with anti-mouse IL-2 antibody (Becton Dickinson)
at a final concentration of 5 mg/ml in PBS. Subsequently, lymph
node cells from immunized mice were cultured on MultiScreen
plates with MOG35-55 or OVA323-339 peptide (in triplicate) at a
concentration of 26105 cells/well. After overnight culture, plates
were extensively washed with water and blocked with 1% BSA in
PBS for 1 hr at room temperature. Subsequently, biotinylated
anti-mouse IL-2 capture antibody (2 mg/ml) and streptavidin-AKP
(Becton Dickinson) were applied for 1 hr at room temperature.
Plates were then washed with water prior to addition of Sigma Fast
BCIP/NBT (Sigma Aldrich) detection reagent. After drying the
plates overnight, the number of spots was calculated with an

I-Ab surface expression
BMDCs WASHfl/fl Vav-Cre+/+ and control Vav-Cre+/+ mice
were scraped from cultures and resuspended at 106 cells/ml in
FACS buffer. Cells were stained for 30 min at 4uC with anti-I-AbPLOS ONE | www.plosone.org
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ELISPOT reader provided by Cellular Technology Ltd. using
dedicated Immunospot Software.

Experimental Autoimmune Encephalitis
Mice were immunized with 50 mg of MOG peptide (myelin
oligodendrocyte glycoprotein amino acids 35–55) emulsified in
IFA containing 50 mg Mycobacterium tuberculosis (strain H37RA) by
subcutaneous injection. At the time of immunization and three
days later, mice received 300 ng of pertussis toxin (List Biological
Laboratories) intravenously. Subsequently, mice were evaluated
daily and scored for development of EAE. Clinical scores of 1–5
were assigned as follows: grade 1 = Tail weakness, grade 2 = hind
limb weakness sufficient to impair righting, grade 3 = one limb
plegic, grade 4 = hind limb paralysis, grade 5 = moribund.

Statistical Methods
Data are expressed throughout as mean + standard deviation.
Data sets were compared using the two-tailed unpaired Student’s
t-test. Statistical analysis (Student’s t-test and column statistics) and
graphing were performed using Prism 4 (GraphPad Software).
Differences were considered statistically significant when p,0.05.

Results
Retromer maintains MHCII plasma membrane levels in
DCs

Figure 1. VPS35 localizes with MHCII and Vps35 is required in
MHCII cell surface retention. (A) BMDCs were transduced with
shRNA constructs targeting VPS35 (shVPS35) or luciferase (shLuc) as a
control. Cells were treated with the Golgi transport inhibitor Brefeldin-A
for a 5-hour chase, and MHCII cell surface expression was determined
by flow cytometry (see Materials and Methods section for details). The
percent of initial MHCII remaining on the plasma membrane after chase
was calculated for three independent samples and plotted as mean
6s.d. To confirm efficient knockdown, VPS35 expression relative to bactin was determined by quantitative PCR. (B) BMDCs were fixed and
labeled with antibodies against MHCII and VPS35 for microscopic
analysis. (C) Following the MHCII endocytosis assay, BMDCs were fixed
and labeled with anti-VPS35. Zoomed images are demarcated by the
white box and dashed lines in the adjacent image. For each condition,
.20 individual cells were imaged. Images were collected with 1006 oil
objective. Scale bars, 10 mm and 1 mm.
doi:10.1371/journal.pone.0098606.g001

We have previously developed an in vitro approach to
systematically identify novel molecules involved in recycling of
MHCII complexes on the surface of immature DCs [23,24,27,33].
In this approach, surface expression of newly synthesized MHCII
is blocked by inhibitors of Golgi transport (Brefeldin-A), permitting
direct analysis of MHCII recycling rates on the plasma membrane
by flow cytometry. After treatment with inhibitors, surface
expression of MHCII is monitored over time to ascertain the rate
of its disappearance, which is referred to as MHCII surface
retention. To discover novel factors required for MHCII recycling,
we used a lentiviral shRNA knockdown screen of candidate
molecules involved in endosomal trafficking. We first focused on
the retromer complex, which is traditionally known for its role in
directing retrograde trafficking of receptors to the Golgi apparatus.
In light of emerging evidence indicating that the retromer may
also direct endosomal cargo back to the plasma membrane
[24,27,28,33], we examined if retromer function is required for
MHCII recycling by depleting it in DCs using shRNA. Efficient
knockdown of VPS35 was confirmed by qPCR prior to
measurement of MHCII retention on the plasma membrane
(Figure 1A, right panel). Strikingly, VPS35 knockdown in DCs led
to a dramatic (40%) reduction in MHCII surface retention over
the course of 5 hours with Brefeldin-A treatment (Figure 1A, left
panel). In contrast, DCs transduced with control shRNA
constructs or mock-transduced DCs exhibited a modest reduction
(20%) of MHCII surface retention (Figure 1 and data not shown).
Furthermore, we observed the accumulation of MHCII in a
VPS35-enriched endosomal compartment (Figure 1B) consistent
with the retromer being involved in the trafficking of MHCII. To
confirm that the localization of MHCII with VPS35 is specific to
endosomal recycling, IF was performed using an endocytosis assay.
Prior to permeabilization, cells were incubated with anti-MHCII
antibody to stain the plasma membrane localized MHCII, and
then incubated to allow internalization. This procedure allowed us
to specifically track cell surface MHCII and the endocytic pathway
involved in it’s recycling. Significantly, we observed similar
localization of MHCII with VPS35 using the endocytosis assay
(Figure 1C) suggesting that the retromer complex is likely involved
PLOS ONE | www.plosone.org

in the recycling of plasma membrane MHCII through a trafficking
route that appears to bypass the Golgi apparatus.

WASH deletion results in an intracellular accumulation of
MHCII
Recent evidence indicates that the WASH complex is involved
in regulating the trafficking of several proteins that are sorted by
the retromer [28]. Notably, while we clearly detect MHCII
staining on both the plasma membrane and endosomes, VPS35
localized directly adjacent to MHCII on intracellular vesicular
structures (Figure 1B and 1C). Consistent with previously
published studies in various cell lines [7–10], we found that DCs
similarly showed a unique distribution pattern of WASH
characterized by punctate spots apposed to the early endosomal
marker EEA1 (Figure 2A and Figure S1A and S1B). Strikingly, costaining revealed that internalized MHCII complexes colocalized
with WASH and EEA1 in DC endosomes (Figure 2A, zoom and
Figure S1A and S1B).
To determine whether MHCII recycling in DCs required
WASH, we used a conditional gene targeting approach in which
Cre recombinase-mediated deletion of loxP-flanked Wash alleles
(Washfl/fl) terminates expression [8,9,11–13]. Mice harboring the
floxed Wash gene were crossed with CD11c-Cre or Vav-Cre

4
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Figure 2. WASH localizes with MHCII in DCs. BMDCs from (A) Cre and (B) WASHf/f Cre were fixed and labeled with anti-MHCII antibody and
WASH for microscopic analysis. (C) Protein lysates prepared from Cre and WASHf/f Cre BMDCs were immunoblotted for WASH and ERK2 (as a loading
control). (D) Images from A and B were analyzed for MHCII co-localization with LAMP1 using Pearson’s co-localization coefficient. MHCII puncta
number and size were quantified by Image J. Zoomed images are demarcated by the white box and lines toward the adjacent image. Differential
interference contrast (DIC) images were used to demarcate the outline of the cell. For each condition, .20 individual cells were imaged. Images were
collected with 1006 oil objective. Scale bars, 10 mm.
doi:10.1371/journal.pone.0098606.g002

transgenic mice, in which the expression of Cre is restricted to DCor hematopoietic-lineage cells, respectively. As an alternative
strategy we generated LysM-Cre+/+ Washfl/fl mice in which
expression of Cre and subsequent deletion of the loxP-flanked
Wash gene occurs in myeloid cells, including macrophages and
monocyte-derived DCs. Importantly, in the absence of WASH, all
DC subsets developed normally in vivo, and bone marrow derived
DC cultures (BMDCs) expanded in GM-CSF with similar kinetics
as wild type cells (Figure S2 and data not shown). Significantly,
WASH-deficient DCs showed a loss of WASH protein by both IF
and immunoblot (Figure 2B and 2C). Interestingly, in the absence
of WASH, MHCII staining was substantially diminished at the
plasma membrane and fewer overall intracellular MHCII positive
puncta were observed (Figure 2B and 2D). Thus, we conclude that
MHCII co-localizes within endosomes where WASH and VPS35
are accumulated.

absent from the colocalized puncta (Figure 2A and zoom). In
contrast, MHCII can be seen co-localizing with LAMP1 in
WASH-deficient DCs (Figure 2B and zoom). Analysis of the
MHCII and LAMP1 puncta confirms that in the absence of
WASH, there are fewer MHCII-positive puncta and MHCII colocalization with LAMP1 in large intracellular puncta increases
significantly (Figure 2D). Taken together these data suggest that
WASH prevents MHCII from accumulating in lysosomes, thus
allowing the recycling of the receptor to the surface. To confirm
that the localization of surface-derived MHCII with WASH is
specific to endosomal recycling, IF was performed using the
endocytosis assay. We observed similar localization of MHCII
with WASH (Figure 3A) and MHCII/WASH localization remains
separate from LAMP1 stained lysosomes (Figure 3A). Again, in
WASH-deficient DCs MHCII can be seen co-localizing with
LAMP1 (Figure 3B and 3C).

WASH prevents the localization of MHCII to lysosomes

WASH-deficiency leads to hyperubiquitination of MHCII

The data presented above suggests that recycling of MHCII in
endosomes involves WASH and retromer. Recently, we reported
that the T cell receptor (TCR) and other molecules expressed by
CD4+ T cells require WASH for efficient trafficking out of the
recycling endosomal network [8,11,12,14,15]. In the absence of
WASH, these receptors were found to accumulate in the lysosome
and were degraded. If MHCII recycling is occurring, WASH and
MHCII should be co-localizing together separate from the
lysosome. To confirm if WASH indeed plays a role in the
prevention of MHCII degradation, we analyzed MHCII localization with lysosomes in wild type and WASH-deficient DCs. Using
antibodies against LAMP1, a lysosome marker, we observed that
WASH and MHCII are co-localized, but LAMP1 is noticeably

The reduced MHCII cell surface retention and rapid degradation of MHCII observed in WASH-deficient DCs suggests that
MHCII may accumulate in endosomes where it can be
ubiquitinated by March1 and marked for degradation by entry
into multivesicular bodies. To assay MHCII ubiquitination, we
immunoprecipitated MHCII from control and WASH-deficient
DCs prior to performing western blots for ubiquitin. In WASHdeficient DCs, the proportion of ubiquitinated MHCII relative to
total levels was dramatically higher than in control DCs, despite
the fact that similar levels of total MHCII were detected by
immunoprecipitation in both genotypes (Figure 3D). Taken
together, our observations in WASH-deficient DCs indicate that
inefficient MHCII recycling from endosomal compartments
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Figure 3. WASH prevents the localization of MHCII into lysosomes following endocytosis. BMDCs derived from (A) Vav-Cre and (B) WASHf/
f
Vav-Cre were cultured with an antibody against MHCII following the endocytosis assay then fixed and labeled with antibodies against WASH and
LAMP1 for microscopic analysis. (C) Images from A and B were analyzed for MHCII co-localization with LAMP1 using Pearson’s co-localization
coefficient in ZEN (Carl Zeiss). Zoomed images are demarcated by the white box and dashed lines in the adjacent images. For each condition, .20
individual cells were imaged. Images were collected with 1006oil objective. Scale bars, 10 mm. Bars represent mean $ SEM. Horizontal lines indicate
statistical comparison between indicated groups, *p#0.05. (D) Ubiquitinated MHCII was detected in BMDCs by immunoprecipitation of total MHCII
followed by immunoblot for ubiquitin (Ub). Blots were subsequently stripped and reprobed with I-Ab antibody as a loading control.
doi:10.1371/journal.pone.0098606.g003

surface stained for I-Ab, the antibody was internalized and
subsequently stripped following incubation after the indicated
times (Figure 4D). Using flow cytometry to measure the mean
fluorescence intensity (MFI) we determined the surface recycling
difference between control DCs and WASH-deficient DCs. If
recycling remained intact, the internalized antibody would return
to the surface and be removed by the stripping buffer, leading to a
reduction in fluorescence. As expected, the control DCs exhibited
a reduction in I-Ab fluorescence whereas the WASH-deficient DCs
demonstrated a minimal reduction in I-Ab fluorescence
(Figure 4D). These data suggest that WASH is involved in the
regulation of MHCII recycling and that in the absence of WASH,
MHCII undergoes limited recycling compared to control DCs.

promotes MHCII ubiquitination, leading to its rapid degradation
in the lysosome.

WASH-deficiency leads to rapid degradation of MHCII
We next examined the overall expression of MHCII on the
surface of WASH-deficient DCs compared to control DCs. Using
antibodies against I-Ab (murine MHCII expressed on DCs from
C57BL/6 mice) and flow cytometry analysis, we found that
WASH-deficient DCs exhibit surface expression of MHCII 2-logs
below that of control DCs (Figure 4A). This suggests that WASH is
responsible for maintaining MHCII surface expression. Next, to
measure MHCII degradation kinetics, we surfaced-labeled control
DCs and WASH-deficient DCs with biotin and chased for up to
7 hours. After the chase, cells were lysed and biotinylated MHCII
was immunoprecipitated and quantification by streptavidin
immunoblot was performed. We observed that MHCII is
degraded in WASH-deficient DCs at a more rapid rate than in
controls (Figure 4B). After a 7-hour chase, WASH-deficient DCs
retained only 40% of surface labeled MHCII, while controls
retained 90% (Figure 4C). These results suggest that WASH is
required for efficient MHCII recycling back to the plasma
membrane and indicate that WASH-dependent trafficking likely
protects MHCII from premature lysosomal degradation.

WASH is required for MHCII antigen presentation
The loss of recycling, hyperubiquitination, and rapid degradation of MHCII that we observed in WASH-deficient DCs predicts
that WASH is required for efficient antigen presentation to T cells.
To assay antigen presentation, we cultured control and WASHdeficient DCs with a constant dose of ovalbumin peptide and wild
type OT-II T cells bearing a transgenic TCR specific for
ovalbumin peptide loaded on I-Ab. After three days in culture,
OT-II T cell proliferation was measured to determine the
efficiency of MHCII antigen presentation by DCs. When peptide
was continuously present throughout the culture period, both
control and WASH-deficient DCs were equally efficient at
inducing wild type OT-II T cell proliferation (Figure 5A). This
finding is consistent with the notion that, even if MHCII half-life is

MHCII recycling is absent in WASH-deficient DCs
To determine if WASH is directly responsible for MHCII
recycling, we used a recycling assay adapted from Sullivan et al.
[8,16]. BMDCs from Washfl/fl and control Cre+/+ mice were
PLOS ONE | www.plosone.org
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Figure 4. WASH-deficiency in DCs leads to polyubiquitination of MHCII and its accelerated degradation. (A) BMDCs from WASHf/f VavCre and control Vav-Cre mice were antibody stained for surface MHCII and analyzed using flow cytometry. Histograms and the bar graph are
representative of six separate experiments. (B) WASHf/f LysM-Cre mice and control LysM-Cre mice BMDCs were surface labeled with biotin and chased
in culture for the indicated time points. After chase, cells were lysed to immunoprecipitate MHCII. Immunoprecipitates were then resolved by PAGE
and processed by immunoblot to detect remaining biotinylated MHCII with streptavidin (SAv). (C) Decay of surface labeled MHCII over time was
measured by densitometry of immunoblots. (D) Percent MHCII recycling was measured on WASHf/f Vav-Cre and control Vav-Cre BMDCs using acid
stripping as described in the Materials and Methods. Data are representative of three separate experiments. Bars represent mean $ SEM, *p#0.05.
doi:10.1371/journal.pone.0098606.g004

mediated trafficking of MHCII is critical for antigen presentation
when antigen is limiting. In this context, endogenous DCs in vivo
encounter antigen in a spatially and temporally restricted manner,
thus the half-life of pMHCII complexes is a critical factor in
priming CD4+ T cell responses.

reduced in WASH-deficient DCs, newly synthesized MHCII can
be loaded with peptide to replace pMHCII complexes that have
been degraded. However, if antigen is limited, and exposure of
DCs to antigen is restricted to a brief encounter, the stability/halflife of pMHCII complexes becomes a critical rate-limiting step for
T cell activation. We therefore performed an experiment in which
control and WASH-deficient DCs were pulsed with ovalbumin
peptide and then thoroughly washed to remove excess antigen.
Under these conditions, when antigen was limited, control DCs
outperformed WASH-deficient DCs in stimulating OT-II T cell
proliferation (Figure 5B).
To determine if WASH is required for MHCII antigen
presentation and CD4 T cell priming in vivo, we employed a
standard immunization protocol. Here, Washfl/fl controls and
Washfl/fl CD11c-Cre mice were immunized in the footpad with
ovalbumin peptide (OT-II). On day 7, we used IL-2 ELISPOT to
enumerate antigen-specific CD4+ T cells in the draining lymph
node. Consistent with our finding that WASH is required for
MHCII antigen presentation in vitro, Washfl/fl CD11c-Cre mice
displayed a 40% reduction in frequency of IL-2 producing,
antigen-specific T cells relative to control mice (Figure 5C). Thus,
lineage specific deletion of WASH in DCs impairs CD4+ T cell
priming in vivo. Based on these findings, we conclude that WASH-
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WASH-deficiency attenuates experimental autoimmune
encephalitis
Having established the requirement for WASH in CD4+ T cell
priming in vivo, we sought to determine whether WASH is also
required for the elicitation of encephalitogenic CD4+ T cells in
experimental autoimmune encephalitis (EAE). Accordingly,
Washfl/fl controls and Washfl/fl CD11c-Cre mice were immunized
with myelin oligodendrocyte glycoprotein peptide 35–55
(MOG35-55) and monitored for development of clinical signs of
disease. In this model of EAE, control mice develop an ascending
paralysis starting at day 14 post-immunization, which progresses
through day 21. However, in Washfl/fl CD11c-Cre mice, disease
onset was delayed and severity was attenuated (Figure 6A). At the
peak of disease, control mice displayed infiltration of mononuclear
cells into the lumbar spinal cord, a finding that was significantly
reduced in Washfl/fl CD11c-Cre mice (unpublished observation).
To determine if attenuation of EAE observed in Washfl/fl CD11c7
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Figure 6. WASH-deficiency impairs priming of autoreactive T
cells and attenuates disease progression in EAE. (A) WASHf/f
CD11c-Cre mice and control WASHf/f mice were immunized by
subcutaneous injection with MOG peptide in CFA to induce experimental autoimmune encephalitis (EAE). Disease progression was
monitored over time using the following scoring system: grade 1 = Tail
weakness, grade 2 = hind limb weakness sufficient to impair righting,
grade 3 = one limb plegic, grade 4 = hind limb paralysis, grade 5 =
moribund. (B) Mice were immunized with MOG peptide as above and
sacrificed at day seven. Draining lymph nodes were harvested and
restimulated in vitro with MOG peptide to enumerate antigen-specific T
cells by IL-2 ELISPOT.
doi:10.1371/journal.pone.0098606.g006

Figure 5. WASH is required for efficient antigen presentation
and T cell priming. (A) BMDCs from WASHf/f LysM-Cre mice and
control LysM-Cre mice were cultured with OT-II T cells and ovalbuminderived peptide antigen at the indicated doses. After three days in
culture, T cell proliferation was determined by flow cytometry and cell
count. (B) Alternatively, BMDCs were first pulsed with peptide antigen,
then washed and cultured at the indicated cell numbers with OT-II T
cells. T cell proliferation was determined by flow cytometry and cell
count after three days. (C) WASHf/f CD11c-Cre mice and control WASHf/f
mice were immunized by subcutaneous injection of ovalbumin peptide
in CFA. Seven days later, draining lymph nodes were harvested and
restimulated in vitro with ovalbumin peptide. Antigen-specific T cells
producing IL-2 upon restimulation were enumerated by ELISPOT.
doi:10.1371/journal.pone.0098606.g005

presentation [8,15,17–23]. To effectively sample environmental
antigens, immature DCs actively synthesize newly formed MHCII
molecules that are continuously loaded with peptide antigen
[8,29–31]. Once loaded, pMHCII complexes briefly recycle from
the plasma membrane through the endosomal system where
March1 ubiquitinates MHCII, thus tagging the complex for
lysosomal degradation [15,20,22]. The relatively short half-life of
pMHCII complexes in immature DCs is essential to promote the
continuous display of newly acquired antigenic peptides on the
plasma membrane [8,18,19]. Thus, while a short pMHCII half-life
promotes antigen sampling in immature DCs, the half-life of
pMHCII must be finely tuned to optimally balance rapid antigen
sampling with extended antigen presentation. In this context, we
have previously shown that impaired pMHCII recycling results in
a marked reduction in its half-life and a corresponding decrease in
efficiency of antigen presentation to CD4+ T cells [17,20–23]. By
identifying the critical role of MHCII recycling in antigen
presentation and T cell priming, our previous work highlights
the importance of deciphering the molecular mechanisms
directing MHCII trafficking. Here we identify WASH and the
retromer component VPS35 as critical determinants of endosomal
recycling in DCs that regulate pMHCII half-life and antigen
presentation to CD4+ T cells.
While the function of retromer components appears to be highly
conserved across phylogeny, we present evidence that DCs use the
retromer to perform a unique and specialized function in MHCII

Cre mice is associated with defective CD4+ T cell priming, we
enumerated MOG-specific IL-2 producing T cells by ELISPOT at
day 7-post immunization, the peak of the T cell response. We
found that Washfl/fl CD11c-Cre mice showed a significant
reduction of autoreactive T cells compared to controls
(Figure 6B). Thus, attenuation of EAE in Washfl/fl CD11c-Cre
mice can be attributed, at least in part, to defective CD4+ T cell
priming. This finding is consistent with the notion that WASH is
required for efficient recycling of MHCII to promote productive
interactions with antigen-specific T cells during antigen presentation.

Discussion
Turnover of the pMHCII complexes in DCs is a highly
regulated process that strictly governs the efficiency of antigen
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recycling. In DCs, MHCII endocytosed from the cell surface and
the retromer-associated WASH complex converge in the endosomal compartment. Accordingly, WASH acts as a critical
mediator of receptor trafficking by coupling the retromer complex
with the actin cytoskeleton. In this context, the sorting nexin
retromer subunits mediate endosomal tubulation, while the
vacuolar protein sorting subunits confer cargo specificity, and
WASH is thought to direct actin polymerization required for
normal endosome structure and domain organization leading to
efficient receptor trafficking [7,9,15,28,32–35]. Importantly, here
we identify a novel mechanism in which DCs employ the
evolutionarily conserved WASH and retromer machinery for
MHCII recycling thus allowing antigen sampling, loading and
presentation resulting in optimal T cell activation.
The observation that DCs require WASH and VPS35 for cell
surface retention of MHCII demonstrates their role in recycling.
Furthermore, in the presence and absence of the Golgi transport
inhibitor Brefeldin-A, MHCII surface levels are retained in control
cells, suggesting that the retromer bypasses the Golgi and recycles
MHCII directly back to the plasma membrane. The notion that
DCs utilize the retromer to route MHCII directly to the plasma
membrane from endosomes represents a novel adaptation of the
retromer. Notably, a precedent exists for the role of retromer
subunits in endosome to plasma membrane recycling
[19,24,27,28]. Recently, HEK293 cells were shown to utilize
WASH and SNX27 for fast recycling of the b2-adrenergic
receptor and resensitization of signaling [23,24]. Moreover,
SNX27 was found to not only interact with distinct cargo, but
also make direct contacts with VPS26 and a component of the
WASH complex to facilitate their trafficking via the retromer
[27,30]. Whether SNX27 or another sorting nexin is involved in
binding MHCII and promoting its subcellular re-routing via
WASH and retromer remains to be determined.
Trafficking of plasma membrane proteins between recycling
and degradative compartments is essential for regulating their halflife and maintaining the spectrum of receptors displayed on the
cell surface. We show that disrupting endosomal recycling by
conditional deletion of WASH in DCs leads to a dramatic
reduction in MHCII half-life, recycling and its accumulation in
polyubiquitinated form. Presumably, impaired recycling traps
MHCII in late endosomes where it encounters the E3 ubiquitin
ligase MARCH1 [18–20,24,36,37]. Following ubiquitination of
the MHCII bchain, it is thought that the ESCRT complex
transports MHCII into luminal vesicles that are subsequently
delivered to lysosomes for degradation. Interestingly, it has been
shown that unstable MHCII dimers accumulate in the lysosome[47]. It is suggested that in the acidic environment of the
lysosome, these unstable MHCII molecules will unfold and
aggregate, become associated with lysosomal chaperones, which
will retain them in the lysosome ultimately leading to their
degradation. Indeed, we show that the loss of WASH leads to an
accumulation of MHCII in lysosomes and we have previously
demonstrated that in the absence of WASH, both the endosomal
and lysosomal systems collapse[9]. Thus, it remains possible that

the lysosomal-accumulated MHCII molecules from the plasma
membrane are unstable and thus being targeted for degradation
instead of being retained in the MHC class-II-containing
compartments for peptide loading.
As a consequence of impaired recycling and rapid degradation
of MHCII, WASH- deficient DCs fail to efficiently present antigen
to T helper cells. Limiting antigen exposure to DCs by a brief
pulse in vitro revealed the requirement for WASH in inducing
proliferation of antigen-specific T cells. Moreover, conditional
deletion of WASH in the DC lineage impairs T cell priming in vivo
and attenuates the clinical course of EAE. Similarly, we have
previously shown that impairment of MHCII recycling by
disruption of the ITAM signaling pathway in DCs prevents
induction of EAE, at least in part due to defective T cell priming
[23,38,39]. Taken together, we have identified a critical requirement for WASH and the retromer in maintaining a stable pool of
pMHCII complexes on the surface of DCs for priming T cell
responses. Thus, DCs utilize the evolutionarily conserved WASH
and retromer complexes to complement their specialized antigen
presenting capacity.

Supporting Information
Figure S1 Endocytosed MHCII transits through the

early endosome. (A) BMDCs derived from Vav-Cre mice were
cultured with an antibody against MHCII following the
endocytosis assay then fixed and labeled with antibodies against
WASH and EEA1 for microscopic analysis. (B) Images from VavCre and (B) WASHf/f Vav-Cre were A were analyzed for MHCII colocalization with EEA1 in Cre and Vav using Pearson’s colocalization coefficient in ZEN (Carl Zeiss). Zoomed images are
demarcated by the white box and dashed lines in the adjacent
images. For each condition, .20 individual cells were imaged.
Images were collected with 1006 oil objective. Scale bars, 10 mm.
Bars represent mean $ SEM. *p#0.05.
(TIFF)
Figure S2 Expression of characteristic cell surface
markers in BMDC cultures. BMDCs from Washf/f LysMCre+/+ mice and control LysM-Cre+/+ mice were stained with the
indicated antibodies and analyzed by FACS. Although WASH
appears to regulate expression of several surface markers,
proliferation and survival of Washf/f LysM-Cre+/+ BMDCs
cultured in GM-CSF were similar to wild type and LysM-Cre+/+
controls.
(TIFF)
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